Biotech Industry Outlook

Top 10 Trends in Biotechnology [2026]: AI, Gene Editing & Biomanufacturing

From AI-designed molecules and CRISPR-based therapies to programmable cells and automated labs, innovation is accelerating in the life sciences. Precision medicine is scaling globally, bioinformatics is becoming core infrastructure, and biomanufacturing is evolving toward flexible, continuous production. At the same time, tissue engineering, bioprinting, and quantum-enabled molecular simulation are expanding. This report maps the top biotech trends reshaping healthcare, research, and industrial biology - along with the startups turning breakthrough science into commercial impact.

Synthetic Biology Market Report [2026]: A Sprint to USD 48.2B by 2029

Synthetic biology is moving into an execution phase where advantage comes from throughput, quality systems, and dependable manufacturing capacity. This 2026 market report maps the funding landscape, scale-up infrastructure, and innovation signals shaping how engineered biology is being operationalized across health, materials, and industrial biomanufacturing.

Genomics Industry Report 2026: 192 600 Patents & 14 100 Funding Rounds

Genomics is scaling beyond sequencing into an execution problem: interpretation, compute, and clinical integration. Our 2026 market report maps 13 630+ companies (including 1235+ startups), 192 600+ patents, and 14 100+ funding rounds with USD 49.1M average round size. These numbers signal that competition is intensifying in analytics, functional genomics, and workflow-ready platforms.